Charles Schwab
TBIO

Charles Schwab’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Charles Schwab’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,441
Closed -$140K – 3670
2022
Q1 		$140K Buy
1,441
+574
+66% +$87K ﹤0.01% 3364
2021
Q4 		$169K Hold
867
– – ﹤0.01% 3381
2021
Q3 		$174K Buy
+867
New +$220K ﹤0.01% 3341

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab's TBIO Position: Q2 2022 in Review

Charles Schwab sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 1,441 shares — an estimated $140K sold.

Charles Schwab first reported a position in TBIO in Q3 2021 and held it in 3 quarters. The position peaked at $174K in Q3 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • Charles Schwab reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 1,441 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $140K.
  • Charles Schwab first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Charles Schwab's Telesis Bio, Inc. Common Stock position peaked at $174K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.